How should a semen analysis showing low volume (2 mL), low sperm concentration (3.2 million/mL), poor motility (5% active initially, virtually none after 1–2 hours) and hormonal levels (FSH 5.7 mIU/mL, LH 4.0 mIU/mL, total testosterone 3.3 ng/mL) be interpreted?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: August 21, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Severe Oligoasthenozoospermia with Normal Hormonal Profile

This semen analysis demonstrates severe oligoasthenozoospermia (severely low sperm count at 3.2 million/mL with profoundly impaired motility) requiring immediate comprehensive andrological evaluation, genetic testing, and consideration for assisted reproductive technologies, as natural conception is highly unlikely with these parameters 1.

Critical Semen Parameter Abnormalities

Your results show multiple severe abnormalities when compared to WHO reference values 1:

  • Sperm concentration: 3.2 million/mL (WHO lower limit: 16 million/mL) - severely reduced
  • Total sperm number: 6.4 million per ejaculate (WHO lower limit: 39 million) - severely reduced
  • Progressive motility: 5% initially, declining to 0% (WHO lower limit: 30%) - profoundly impaired
  • Total motility: 15% initially, declining to 0% (WHO lower limit: 42%) - profoundly impaired
  • Volume: 2.0 mL (WHO lower limit: 1.4 mL) - borderline low-normal
  • Morphology: 51% normal forms (WHO lower limit: 4%) - normal

The rapid decline in motility (100% immotile by 2 hours) is particularly concerning and suggests either severe sperm dysfunction or possible oxidative stress 2.

Hormonal Profile Interpretation

Your hormonal values are all within normal reference ranges 1:

  • FSH: 5.74 mIU/mL (normal: 1.5-12.4) - normal
  • LH: 4.03 mIU/mL (normal: 1.24-7.8) - normal
  • Total testosterone: 3.3 ng/mL (normal: 2-8) - normal, though on lower end

**The combination of normal FSH (<7.6 IU/L) with severe oligozoospermia is significant** 1. This pattern suggests that testicular failure is NOT the primary cause, as FSH would typically be elevated (>7.6 IU/L) in non-obstructive azoospermia or severe spermatogenic failure 1. Your normal FSH indicates preserved testicular reserve and suggests either:

  1. Partial obstruction (though volume and pH argue against complete distal obstruction)
  2. Functional sperm production defect with compensated hormonal axis
  3. Genetic abnormalities affecting spermatogenesis
  4. Oxidative stress or environmental factors 2

Mandatory Next Steps

1. Genetic Testing - REQUIRED

You meet criteria for mandatory genetic testing 1:

  • Karyotype analysis: Required for sperm concentration <5 million/mL 1
  • Y-chromosome microdeletion testing: Required for severe oligozoospermia (0-5 million/mL range has 5% prevalence of microdeletions) 1

These tests are critical before considering assisted reproduction, as certain genetic abnormalities (Klinefelter syndrome, Y-microdeletions) have implications for offspring and treatment options.

2. Repeat Semen Analysis

Obtain at least one additional semen analysis 1 month apart 1. Semen parameters are highly variable biological measures, and a single test cannot definitively characterize fertility potential 1. The repeat analysis should be performed at a specialized andrology laboratory with 3-5 days abstinence 3.

3. Physical Examination Focus

Essential examination findings to determine 1:

  • Testicular volume (normal vs. atrophic - use orchidometer)
  • Vas deferens presence bilaterally (absence suggests CBAVD)
  • Epididymal examination (induration/dilation suggests obstruction)
  • Varicocele assessment (palpable varicoceles may be treatable)

4. Additional Investigations to Consider

  • Scrotal ultrasound: Only if varicocele suspected on exam or to confirm testicular volume 1
  • Oxidative stress testing: Given the rapid motility decline, oxidative stress assessment may be valuable 2
  • Transrectal ultrasound (TRUS) or pelvic MRI: NOT indicated in your case, as these are reserved for suspected ejaculatory duct obstruction (volume <1.4 mL, acidic pH <7.0, azoospermia) 1. Your volume is 2.0 mL with normal pH 7.6, making distal obstruction unlikely.

Fertility Prognosis and Treatment Pathway

Natural conception is highly improbable with these parameters. With sperm concentration of 3.2 million/mL and virtually absent motility, you fall well below thresholds for intrauterine insemination (requires >9 million total motile sperm) 4.

Your treatment pathway will likely require:

  1. In vitro fertilization (IVF) with intracytoplasmic sperm injection (ICSI) - the most appropriate assisted reproductive technology for severe male factor infertility
  2. Lifestyle optimization: Address modifiable risk factors (smoking cessation, weight optimization, avoid excessive heat exposure, minimize environmental toxins) 2, 1
  3. Antioxidant therapy: May improve sperm quality in cases of oxidative stress 2
  4. Varicocele repair: Only if palpable varicocele identified on examination 1

Critical Caveats

  • Do not delay genetic testing - results will guide reproductive counseling and treatment options
  • Partner evaluation should occur simultaneously - 50% of infertility involves both partners 2
  • FSH may rise over time: Men with "compensated hypospermatogenesis" (normal FSH with abnormal semen) can experience declining parameters 4
  • Beware of home/mail-in semen tests - they lack the accuracy of specialized andrology laboratory testing 1

The normal pH (7.6) and adequate volume (2.0 mL) effectively rule out complete distal genital tract obstruction (CBAVD, ejaculatory duct obstruction), which would present with volume <1.4 mL and acidic pH <7.0 1.

Related Questions

Is an elevated follicle‑stimulating hormone (FSH) level of 9.7 IU/L concerning for future decline in fertility despite a normal sperm concentration of 60 million per milliliter, and what can be done to preserve fertility over the next 3–5 years?
What does elevated follicle‑stimulating hormone (FSH) and low sex‑hormone‑binding globulin (SHBG) indicate in a male, and how should it be evaluated and managed?
What does a serum follicle‑stimulating hormone (FSH) level of 137 IU/L indicate in a female, and what are the appropriate management steps?
For a 66-year-old man with elevated follicle‑stimulating hormone (FSH) 27.2 IU/L, normal luteinizing hormone (LH) 7.2 IU/L, total testosterone 549 ng/dL, free testosterone 111 pg/mL, and sex hormone‑binding globulin (SHBG) 37 nmol/L, what is the recommended management regarding scrotal ultrasound, urology referral, and treatment?
What is the appropriate workup for decreased ejaculate volume in a 73-year-old male?
Is spironolactone appropriate for treating female androgenic alopecia, and what dosing and monitoring are recommended?
What does a fasting glucose of 135 mg/dL indicate in a diabetic patient?
What is the appropriate management for a young female with an arachnoid cyst causing subfalcine herniation, no neurological deficits, and no papilledema?
What supplements and nutrition should an adult recovering from Achilles tendon repair take to optimize recovery?
What should I know about lumbar and thoracic epidurals, including level‑specific considerations, expected sensory block, and potential complications?
Can a patient with bipolar II disorder who has had only two brief hypomanic episodes without functional impairment take Adderall (mixed amphetamine salts)?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.